
Jennifer Kearney-Strouse
Articles
-
1 month ago |
immattersacp.org | Gianna Melillo |Charlotte Huff |Jennifer Kearney-Strouse |ACP Internist
As a member of the first-ever group of editorial fellows at Annals of Internal Medicine, Yuri Matusov, MD, FACP, got an in-depth look at what makes an academic medical journal tick. Over the 12-month program, from July 2023 to June 2024, he and three other participants learned peer review from the inside out, evaluating manuscripts being considered for publication in Annals as well as abstracts submitted to ACP's annual abstract competitions.
-
1 month ago |
immattersacp.org | Gianna Melillo |Charlotte Huff |Jennifer Kearney-Strouse |ACP Internist
https://immattersacp.org/archives/2025/03/controlling-cirrhosis-preventing-stroke-and-more-stories.htm This month's issue covers cirrhosis, stroke, and peer review, among other topics. The burden of cirrhosis in the U.S. population has been increasing, with noted disparities by age, sex, and geography. While patients with decompensated disease are usually easy to spot, compensated cirrhosis can sometimes be hiding in plain sight.
-
1 month ago |
immattersacp.org | Gianna Melillo |Charlotte Huff |Jennifer Kearney-Strouse |ACP Internist
Vector-borne diseases have typically been considered a threat in warm climates. But during the ACP/Annals of Internal Medicine virtual forum “Emerging and Resurging Vector-Borne Diseases,” Christine Laine, MD, FACP, pointed out that the conventional wisdom is changing.
-
1 month ago |
acphospitalist.acponline.org | Jennifer Kearney-Strouse |Gianna Melillo |ACP Hospitalist
The American Geriatrics Society updated its position statement on older adults who lack medical decisional capacity, an advance directive, and a surrogate decision-maker. Two of the authors discuss putting the advice into practice.
-
Nov 1, 2024 |
immattersacp.org | Charlotte Huff |Gianna Melillo |Jennifer Kearney-Strouse |ACP Internist
https://immattersacp.org/archives/2024/11/alzheimers-disease-early-onset-cancer-and-more-stories.htm This month's issue covers Alzheimer's disease, breast cancer mutations, and "skinny label" generic drugs. Physicians managing patients with Alzheimer's disease have gained some new potential tools over the past few years, with increased availability of blood biomarker testing and two new drugs aimed at slowing cognitive decline.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →